On March 1, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following virtual healthcare conferences (Press release, Iovance Biotherapeutics, MAR 1, 2021, View Source [SID1234575950]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference – Cell Therapy Panel
Date/Time: Wednesday, March 3, at 1:20 p.m. ET
H.C. Wainwright Global Life Sciences Conference
Date/Time: Tuesday, March 9, at 7:00 a.m. ET
Barclays Global Healthcare Conference
Date/Time: Thursday, March 11, at 1:50 p.m. ET
Oppenheimer 31st Annual Healthcare Conference
Date/Time: Wednesday, March 17, at 1:10 p.m. ET
The live and archived webcasts of the presentations will be available in the Investors section of the Iovance website at View Source